Invention Grant
US09265778B2 Compositions for oral administration of zoledronic acid or related compounds for treating multiple myeloma
有权
用于口服施用唑来膦酸或相关化合物治疗多发性骨髓瘤的组合物
- Patent Title: Compositions for oral administration of zoledronic acid or related compounds for treating multiple myeloma
- Patent Title (中): 用于口服施用唑来膦酸或相关化合物治疗多发性骨髓瘤的组合物
-
Application No.: US14279226Application Date: 2014-05-15
-
Publication No.: US09265778B2Publication Date: 2016-02-23
- Inventor: Herriot Tabuteau
- Applicant: Antecip Bioventures II LLC
- Applicant Address: US NY New York
- Assignee: ANTECIP BIOVENTURES II LLC
- Current Assignee: ANTECIP BIOVENTURES II LLC
- Current Assignee Address: US NY New York
- Agency: K&L Gates LLP
- Agent Louis C. Cullman; Brent A. Johnson
- Main IPC: A61K31/675
- IPC: A61K31/675 ; A61K31/663 ; A61K9/20 ; A61K9/00 ; A61K9/28
Abstract:
Oral dosage forms of bisphosphonate compounds, such as zoledronic acid, can be used to treat or alleviate pain or related conditions. The oral bioavailability of zoledronic acid can be enhanced by administering the zoledronic acid in the disodium salt form.
Public/Granted literature
Information query
